Eurofins-Cerep SA operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eurofins-Cerep SA with three other
companies in this sector in France:
sales of 18.19 million Euro [US$20.14 million]
of which 98%
Ose Immunotherapeutics SA
(24.46 million Euro [US$27.08 million]
(20.09 million Euro [US$22.24 million]
During the year ended December of 2018, sales at
Eurofins-Cerep SA were 25.45 million Euro (US$28.19 million).
increase of 4.3%
versus 2017, when the company's sales were 24.41 million Euro.
This was the fourth straight year of sales growth at Eurofins-Cerep SA.